Multiplicities in cancer research: ubiquitous and necessary evils

癌症研究中的多重性:普遍存在且必要的弊端

阅读:1

Abstract

Scientific inquiry involves observations and measurements, some of which are planned and some of which are not. The most interesting or unusual observations might be regarded as discoveries and therefore particularly worthy of publication. However, the observational process is fraught with inferential land mines, especially if the discoveries are serendipitous. Multiple observations increase the probability of false-positive conclusions and have led to many false and otherwise misleading publications. Statisticians recommend adjustments to final inferences with the goal of reducing the rate of false positives, a strategy that increases the rate of false negatives. Some scientists object to making such adjustments, arguing that it should not be more difficult to determine the validity of a discovery simply because other observations were made. Which tack is right? How does one decide that any particular scientific discovery is real? Unfortunately, there is no panacea, no one-size-fits-all approach. The goal of this commentary is to elucidate the issues and provide recommendations for conducting and reporting results of empirical studies, with emphasis on the problems of multiple comparisons and other types of multiplicities, including what I call "silent multiplicities." Because of the many observations, outcomes, subsets, treatments, etc, that are typically made or addressed in epidemiology and biomarker research, these recommendations may be particularly relevant for such studies. However, the lessons apply quite generally. I consider both frequentist and Bayesian statistical approaches.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。